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Introduction {#sec1}
============

Although considerable progress has been made in understanding the cues that direct self-renewal and differentiation of pluripotent stem cells ([@bib6]), the factors and pathways capable of perpetuating any multipotent tissue-specific progenitor in the absence of immortalizing genetic modifications remain largely undefined. During development, reciprocal interactions between the ureteric bud (UB) and the surrounding metanephric mesenchyme (MM) direct the formation of the metanephros. The MM promotes the branching morphogenesis of the UB to generate the collecting duct network. In turn, the UB induces condensation and mesenchymal-epithelial transition (MET) in the MM to initiate nephron formation at each bud tip. Condensed cells of the MM cap the tips of the branching UB in the cortical nephrogenic zone of the metanephros and provide a self-renewing population of SIX2+ progenitors, which supply the precursors for nephronic epithelia ([@bib13]). Ablation of *Six2* results in the premature commitment of these progenitors and a depletion of the progenitor pool. Therefore, SIX2 is a major determinant in the maintenance and self-renewal of the nephronic precursor. The aggregate SIX2-expressing population is further regulated by the transcriptional co-activator and Hippo pathway component Yes-associated protein (YAP) and is growth-limited by signals emanating from the encapsulating cortical stroma ([@bib8]). The loss of stromal signals promotes the expansion of undifferentiated SIX2+ stem cells, stimulates the nuclear localization of YAP, and inhibits the formation of nephronic structures. Conversely, *Yap* ablation causes renal hypoplasia, characterized by a measureable deficit in progenitor self-renewal and fewer nephrons. These findings led us to hypothesize that constitutive activation of SIX2 and YAP is sufficient to sustain this tissue-specific stem cell.

During development, extrinsic signals in a progenitor's microenvironment provide cues for self-renewal and lineage commitment. Although several growth factors, including fibroblast growth factors (FGFs) 2 ([@bib21]), 8 ([@bib22]), 9, and 20 ([@bib1]) and epidermal growth factor (EGF)/transforming growth factor α (TGF-α) ([@bib25]), support the survival of MM cells and facilitate the limited expansion of this population in culture, they have proven to be insufficient for long-term propagation of progenitors with stem-like properties and nephronic potential. In this study, we optimize the niche for rat progenitors using growth factors, extracellular matrix, and Rho kinase inhibitor, which, in combination, sustain SIX2 and YAP nuclear expression. Moreover, we demonstrate that these factors contribute to the preferential propagation and partial stabilization of MM progenitors with the preservation of stem cell markers and a capacity for differentiation.

Results {#sec2}
=======

The Extracellular Matrix Helps Stabilize MM Progenitors {#sec2.1}
-------------------------------------------------------

Primary cultures of MM were generated from developmentally comparable embryonic day (E) 13.5 rat or E11.5 mouse metanephric rudiments ([Figure 1](#fig1){ref-type="fig"}A). MMs were dissected from trypsin-treated metanephroi and cultured as intact masses (10/60-mm dish) for up to 10 days using 50 ng/ml FGF2 and 10 ng/ml TGF-α (referred to as FT medium) to promote the survival and growth of cells ([@bib21; @bib23]). To establish whether these conditions support progenitor self-renewal, primary cultures of rat MMs (rMMs) in FT medium were analyzed for markers associated with cap mesenchyme or MM progenitor maintenance, i.e., *Six2*, *Pax2* ([@bib13; @bib35]), and *Cited1* ([@bib24]), by qPCR ([Figure 1](#fig1){ref-type="fig"}B; [Figure S1](#mmc1){ref-type="supplementary-material"}A). Compared with uncultured rMM controls, cells grown on regular tissue culture dishes showed substantial loss of expression of each of these markers, indicating that FT conditions were inadequate for long-term SIX2+ progenitor propagation. To stabilize stem cell marker expression, culture conditions were modified through the addition of matrix coatings, growth factors, and small-molecule inhibitors.

The extracellular matrix associated with nephron formation is restructured radically at MET in vivo. During this morphogenesis, laminin replaces fibronectin in newly formed epithelia ([@bib10]). To determine whether the matrix itself helps stabilize the progenitors, primary explants (2/well) in FT medium were seeded onto matrix-coated, 24-well culture dishes and examined after 10 days for expression of progenitor markers and cell proliferation. Compared with dishes bearing no matrix, cells on fibronectin or laminin expressed elevated levels of the progenitor markers *Six2* and *Cited1* ([Figure S1](#mmc1){ref-type="supplementary-material"}A). Matrigel stimulated a 10-fold increase in the epithelial marker *Lim1*, suggesting that cells were differentiating on this coating, and its use was discontinued. Cell proliferation was also evaluated, but cell numbers were not significantly affected by changes in matrix ([Figure S1](#mmc1){ref-type="supplementary-material"}B). Given the ability of matrix coatings to elevate the expression of stem markers, fibronectin- or laminin-coated dishes were employed in all subsequent studies.

LIF and the Rho Kinase Inhibitor Y27632 Support the Self-Renewal of MM Progenitors {#sec2.2}
----------------------------------------------------------------------------------

Leukemia inhibitory factor (LIF) induces MET in primary rMM cells, generating tubules and glomerulus-like structures ([@bib2; @bib23]). It is expressed both by the UB and MM, whereas LIF receptors are found on cap progenitors and newly formed nephronic epithelia ([@bib23]). Because LIF treatment also greatly expanded the size of rMM explants, we postulated a role for LIF in rMM self-renewal. Moreover, the Rho kinase inhibitor Y27632 or a dominant-negative *RhoA* construct also increased the size of cultured mouse MM (mMM) colonies ([@bib18]). Accordingly, we investigated the ability of these two factors to regulate the growth of rMMs in culture. For this, ten primary rMM explants were seeded onto fibronectin-coated wells of 6-well dishes and treated for 10 days, with medium replacement every 2--3 days. Individually both LIF (1 ng/ml) and Y27632 (10 μM) nearly doubled cell counts relative to controls in FT medium, and simultaneous treatment yielded numbers nearly four times those of controls, demonstrating that both factors contribute independently to the proliferation of rMMs ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Furthermore, 5 ng/ml LIF yielded no significant increase over the 1 ng/ml treatment, suggesting that the lower level is optimal for growth. Based on final cell counts, the population expansion was achieved with more than eight cell doublings during the 10-day period.

To determine whether LIF stimulation or Rho kinase inhibition stabilized the expression of stem cell markers, cells were evaluated for *Six2* and *Pax2* expression. Cultured rMMs were treated with LIF (0.5--10 ng/ml) or Y27632 (5.0--20 μM) in FT medium to maximize marker expression and minimize any concomitant stimulation of expression of the differentiation marker *E-cadherin*. For these studies, primary explants of MM (3/well in a 24-well laminin-coated plate) were cultured for 10 days and then analyzed by qPCR. Overall, the highest concentrations of LIF and Y27632 supported the most robust expression of *Six2* and *Pax2* ([Figure 1](#fig1){ref-type="fig"}B). Levels of *Six2* expression were three times greater than those observed in uncultured rMMs, whereas *Pax2* levels approached those of uncultured MMs. However, *E-cadherin* expression was also elevated greatly (\>15-fold), suggesting that these higher levels shifted the balance between stemness and commitment to MET ([Figure 1](#fig1){ref-type="fig"}C). In combination with FT factors, lower levels of LIF (1 ng/ml) and Y27632 (10 μM) provided the best balance, supporting expression of both stem cell markers with only a 2-fold induction of *E-cadherin*. This will be referred to hereafter as FTLY medium. When the study was expanded to evaluate the expression of several markers of intermediate mesoderm, rMMs, condensed mesenchyme (e.g., *Cited1*, *Pax2/8*, *Osr1*, *Sall1*, *Six1/2*, and Wt*1*), or stroma (*Foxd1*, *Pbx1*, and *Meis1/2*) by semiquantitative RT-PCR, the expression levels of FTLY-treated cells were generally equal to or greater than those of the progenitors (rMM lane) from which they were derived ([Figure 1](#fig1){ref-type="fig"}D). Again, FT-treated cultures failed to maintain *Pax2* expression. *Bmp7* has previously been linked to proliferation of these progenitors ([@bib3]), and our conditions also stabilized its expression, suggesting that stimulation of growth may be mediated in part by this factor. Interestingly, the stromal progenitor marker *Foxd1* was greatly reduced in FTLY medium, whereas the stromal markers *Pbx1* and *Meis 1/2* increased, suggesting that FTLY either does not support self-renewal of stromal progenitors or that it facilitates their conversion to SIX2+ progenitors, which is less likely given the increased *Pbx1/Meis1/2* levels with FT and FTLY media.

Progenitor status was further documented by immunofluorescence (IF) staining for the stem cell markers SIX2, PAX2, and SALL1, all of which localize to the nucleus during development ([Figure 2](#fig2){ref-type="fig"}A; [Figure S2](#mmc1){ref-type="supplementary-material"}). Cells were grown for 10 days in FTLY medium and then dissociated and replated in FT or FTLY medium for 3 additional days on laminin-coated, 4-well chamber slides (50,000 cells/well). When probed for SIX2, rMM cells showed frequent nuclear staining in FTLY-treated cultures but only limited staining in FT-treated control cultures. Similarly, nuclear staining for PAX2 was more prominent in FTLY-treated cultures. SALL1, on the other hand, was detected in the nuclei of both control (FT-treated) and FTLY-treated cultures ([Figure S2](#mmc1){ref-type="supplementary-material"}). These observations are consistent with our results from gene expression studies and suggest an association between FTLY treatment and the increased incidence of SIX2 nuclear expression.

To quantify the effects of FTLY treatment on the SIX2+ progenitor population in mixed MM cultures, cells were analyzed for nuclear expression of SIX2 or the stromal marker PBX1 ([@bib4]) by IF. Freshly isolated rMMs contained ∼30% SIX2+ and 70% PBX1+ cells ([Figures 2](#fig2){ref-type="fig"}B and 2C). For unpassaged cells, 3 explants/well were dispersed by pipetting and seeded in 4-well, fibronectin-coated chamber slides. With FTLY treatment for 7 days, the SIX2**+** population increased to nearly 50%, whereas FT treatment caused a 50% decline in the SIX2**+** population. Therefore, FTLY not only sustained the SIX2+ progenitors but also preferentially expanded this population. To assess the population dynamics in subsequent passages, cells were dissociated with trypsin and evaluated as monolayer cultures. Confluent cells were trypsinized and seeded into chamber-slide wells (50,000 cells/well) with fixation the following day. The SIX2+ population peaked at over 65% by passage 2. By passage 3, however, the FTLY-expanded SIX2**+** population declined and was largely replaced by SIX2−/PBX1−/CADHERIN6(CDH6)**+** epithelium-like clusters ([Figure S3](#mmc1){ref-type="supplementary-material"}). CDH6 is primarily expressed in newly formed nephronic epithelium ([@bib7]), suggesting that the SIX2+ cells had initiated MET. These clusters did not stain for E-CADHERIN (ECDH, data not shown), consistent with progression only to primitive epithelium. Regardless, a significant percentage of cells (∼8%) remained SIX2**+** in FTLY-treated passage 5 cultures, demonstrating that SIX2**+** progenitors are preserved and persist in multi-passaged populations. Immunoblots also showed a decline in SIX2 protein levels from four separate cultures of rMM cells at passages 1, 3, and 5 ([Figure 2](#fig2){ref-type="fig"}D), consistent with the loss of SIX2+ cells. Concordant with immunostaining, ECDH was not detected in later passages.

We further examined the ability of FTLY medium to sustain the expression of several progenitor markers in long-term cultures. RT-PCR gene expression profiles were generated from passage 5 cells. For this, cells were briefly trypsinized (2--3 min) and split one to three. Cells were then passaged just prior to reaching confluence (every 4--5 days). Therefore, by passage 5, cells had been in culture for nearly 1 month. The profile for passage 5 FTLY-treated MMs still closely resembled that for uncultured rMMs with retention of *Six2*, *Eya1*, *Sall1*, *Cited1*, *Pax2*, and *Hoxa11*, whereas the differentiation markers *Lim1* and *E-cadherin* were reduced greatly ([Figure 2](#fig2){ref-type="fig"}E). On the other hand, FT-treated cultures showed reduced levels of expression of most of the progenitor markers relative to FTLY treatment, demonstrating a significant improvement in long-term progenitor maintenance.

LIF/Rho Kinase Inhibitor Preserves the Capacity of rMM Progenitors to Respond to Inductive Signaling {#sec2.3}
----------------------------------------------------------------------------------------------------

To assess whether progenitors retained an ability to epithelialize upon cue, rMMs grown in FT or FTLY medium for 10 days were trypsinized and plated in FT medium without or with WNT4 (100 ng/ml). Expression of the differentiation markers *Lim1* and *E-cadherin* was upregulated 3- to 4-fold with a 72-hr WNT4 treatment ([Figure 3](#fig3){ref-type="fig"}A). Passage 5 cells also responded to a 3-day induction with LIF (50 ng/ml) or the GSK3β inhibitor CHIR99021 (1 μM) by upregulating the expression of the differentiation markers *Lim1* and *E-cadherin* only when cells had been propagated continuously in FTLY medium ([Figure 3](#fig3){ref-type="fig"}B). To evaluate this responsiveness more rigorously, primary and passaged rMM cells were assessed for their ability to form colonies on WNT4-expressing NIH 3T3 cells. Only multipotent MM progenitors generate colonies in this assay and exhibit multi-lineage differentiation from a single progenitor ([@bib18]). For these studies, WNT4-expressing NIH 3T3 cells that had been placed in stasis by treatment with mitomycin C were seeded into wells (500,000 cells/well) of a fibronectin-coated, 12-well plate in DMEM with 10% fetal bovine serum (FBS). The following day, 100,000 rMM cells were added per well in a colony assay medium. Only sizable colonies (\>10 cells) were counted. In this study, no colonies were observed in co-cultures containing 100,000 rMM cells propagated in FT control medium for 10 days, whereas cells grown in FTLY medium for 10 days sustained the ability to form colonies at a level greater than 50% that of uncultured rMMs ([Figure 3](#fig3){ref-type="fig"}C). The frequency of colony formation declined with passage, but small numbers of WNT4-responsive colonies were consistently observed even at passage 5, again demonstrating the preservation of a competent progenitor population in these cultures.

Cultured cells were also assessed for their ability to form nephronic epithelia and undergo segmentation. For this, cells maintained in FT or FTLY medium were passaged and then co-cultured with embryonic spinal cord. Initially, 100,000 rMM cells were allowed to aggregate in wells of a 96-well, low-binding affinity plate for 48 hr and then transferred to filters with embryonic spinal cord. They were then cultured for 8 days on medium with 10% FBS. Under these conditions, control (FT-treated) cells at first passage yielded small, necrotic aggregates with some primitive epithelia that were devoid of any glomerulus-like structures ([Figure 3](#fig3){ref-type="fig"}D). Some aggregates expressed WT1, a marker of condensed mesenchyme, and the epithelia exhibited ECDH or CDH6 staining, which label distal and proximal tubules, respectively. However, NEPHRIN, a glomerular marker, was never detected. This is consistent with the induction of primitive epithelia by FGF2 ([@bib11]). By passage 2, all FT-treated cultures failed to form even primitive epithelia or stain for any nephron markers ([Figure 3](#fig3){ref-type="fig"}D). On the other hand, FTLY-treated and passaged cells were expanded dramatically, preserved well, and populated with numerous tubules and glomerulus-like structures at both passages ([Figure 3](#fig3){ref-type="fig"}D; [Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). NEPHRIN staining was demonstrable in glomerulus-like foci, and expression of both CDHs was robust. Therefore, FTLY medium preserved the competence of progenitors to form mature segmented nephronic epithelia. Attempts to induce later-passage cells with embryonic spinal cord, however, were unsuccessful. This likely reflects the depletion of SIX2+ progenitors at passage 3, but, as noted, their loss did not preclude the ability of the remaining cells to respond to inductive signals.

Mouse MM Progenitors Are Also Preserved with LIF/ROCKi Treatment {#sec2.4}
----------------------------------------------------------------

In addition to rat MM cells, comparable culture conditions were applied to mMM cells isolated from E11.5 embryos. Cells were expanded with FTLY medium and then passaged in FT medium with or without LIF or Y27632 for 48 hr. By IF, the majority of cells showed nuclear SIX2 staining in LIF-treated cultures, whereas only a small fraction of cells in FT-treated cultures had stained nuclei ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Furthermore, the expression of stem cell markers after 10 days was preserved only with the addition of LIF ([Figure S5](#mmc1){ref-type="supplementary-material"}B). At 1--5 ng/ml, the expression of *Six2*, *Cited1*, and *Sall1* was robust, and *E-cadherin* was minimized. Furthermore, when FTLY-treated cells were exposed to the GSK3β inhibitor CHIR99021, both *Lim1* and *E-cadherin* were upregulated ([Figure S5](#mmc1){ref-type="supplementary-material"}C), suggesting that mMM also remained competent to respond to induction.

LIF Activates STAT Signaling to Sustain SIX2 {#sec2.5}
--------------------------------------------

LIF functions primarily through the activation of a Janus kinase to phosphorylate a STAT molecule, which then oligomerizes and moves to the nucleus for transcriptional activation ([@bib29]). Phosphorylation occurs within minutes of LIF exposure. However, STAT upregulates its own expression, yielding high levels of an unphosphorylated form (U-STAT), which also binds DNA ([@bib34]) to activate or repress gene transcription ([@bib37]). Multiple STAT family members are expressed in the developing metanephros ([@bib36]), so we assessed the ability of LIF to induce phosphorylation of those STATs. Although 1 ng/ml LIF is optimal for rMM self-renewal, we reported that higher levels (50 ng/ml) induce MET in progenitors ([@bib23]). Therefore, we evaluated phosphorylation at both concentrations. In rMM cells, STATs 1, 3, 4, 5, and 6 were all expressed and could be activated by LIF. However, LIF stimulated the phosphorylation of only STATs 1, 3, and 5 at 1 ng/ml, suggesting that these STATs mediate LIF signals in our progenitors ([Figure 4](#fig4){ref-type="fig"}A). Y27632 elicited no effect on STAT phosphorylation. These findings confirm that LIF activates canonical STAT signaling in cultured rMM cells and establishes redundancy in STAT responses to LIF.

To directly assess the role of STAT signaling in the maintenance of the stem cell phenotype, *Stats* were knocked down individually or collectively with small interfering RNA (siRNA) in rMM cells monitored for SIX2 expression ([Figure 4](#fig4){ref-type="fig"}B). Cells (10^6^) were transfected using Lipofectamine RNAi MAX and cultured for 3 days in a fibronectin-coated 12-well plate. Consistent with a role in stem cell stabilization, knockdown (KD) of *Stats 1*, *3*, or *5* individually showed reduced levels of SIX2 expression. Furthermore, the greatest SIX2 reduction was observed with KD of all three *Stats*. The resulting partial attenuation of SIX2 may either reflect the involvement of other factors in regulating its expression or possibly the loss of preferential growth of the SIX2+ progenitor. Nuclear levels of stem cell markers were also evaluated in cells treated with FT plus LIF (1 ng/ml) or Y27632 after 3 days in culture. Individually, both LIF and Y27632 treatments increased nuclear SIX2 levels ([Figure 4](#fig4){ref-type="fig"}C). Furthermore, the combination greatly increased nuclear levels of pPAX2. FGF2 is known to activate STAT signaling ([@bib17]), so it is not surprising that FT (control) medium also induced nuclear STAT3. LIF, however, overcame the attenuating effects of Y27632 on nuclear STAT3. These studies suggest that both LIF and Y27632 regulate nuclear levels of SIX2 and PAX2, but, again, this result could be explained either by growth selection of the SIX2+ cell or by induction of expression.

Because cytosolic SIX2 was not demonstrable in immunoblots ([Figure 4](#fig4){ref-type="fig"}C), we hypothesized that this transcription factor is unstable outside of the nucleus. To test this, cells were exposed to the proteasomal inhibitor MG132 and harvested as above. Under these conditions, a prominent cytosolic band of the appropriate size was detected ([Figure S6](#mmc1){ref-type="supplementary-material"}A), indicating that SIX2 is degraded rapidly in the cytoplasm and suggesting that any cytoplasmic IF staining for SIX2 is attributable to its degradation products.

To better understand a possible relationship between STAT activation and *Six2* expression, we examined direct binding of STAT3 to the *Six2* promoter using a chromatin immunoprecipitation (ChIP) assay. Because the mouse genome has been much more rigorously sequenced and annotated in the *Six2* promoter than the rat genome, mMM cells were used for ChIP analysis. Isolated mMM cells were propagated in FT or FTL (5 ng/ml LIF) medium to confluence (6--8 days). In silico analysis of the *Six2* proximal promoter revealed two clearly defined *Stat* consensus binding sites (*StatRE1* and *StatRE2*) within 5 kb of the start codon ([Figure 4](#fig4){ref-type="fig"}D, top). *Socs3* is a well established direct target for STAT3 binding and was included as a positive control ([Figure 4](#fig4){ref-type="fig"}D, center). LIF treatment significantly increased STAT3 binding to the *Socs3* promoter, demonstrating the efficacy of the procedure. Similarly, STAT3 binding to the *Six2* promoter was enhanced with LIF treatment, exhibiting a nearly 6-fold enrichment in recruitment to the *Six2 StatRE1* relative to *StatRE2* ([Figure 4](#fig4){ref-type="fig"}D, bottom). Therefore, STAT3 binds directly to the *Six2* promoter. Given that binding is plotted relative to an internal control, a lower-affinity *StatRE2* site, the 6-fold differential between StatRE1 and StatRE2 is likely due to a bona fide increase in binding rather than merely a selection for the SIX2+ progenitor, although we cannot rule out the latter.

LIF Differentially Activates PLCγ to Suppress SIX2 Expression {#sec2.6}
-------------------------------------------------------------

As mentioned above, LIF mediates opposing concentration-dependent activities in rMM cells. To better understand the basis for this, we evaluated the ability of LIF to activate CALCINEURIN/calcium signaling as described previously for Wnt4 ([@bib32]). When cultured rMMs were induced with 50 ng/ml LIF, both differentiation markers, *Lim1* and *E-cadherin*, were upregulated after 6 days of treatment ([Figure 5](#fig5){ref-type="fig"}A). However, cyclosporine A (CsA), a CALCINEURIN/NFAT inhibitor, blocked the ability of LIF to induce the expression of these markers, whereas the β-CATENIN inhibitor CT-HC-1 had no effect on differentiation. Therefore, both LIF and WNT4 mediate MET through a calcium-dependent mechanism. Because the PHOSPHOLIPASE C (PLC) metabolite inositol 1,4,5-trisphosphate stimulates calcium release and uptake and because JAK/STAT signaling can also initiate a calcium cascade through PLC activation ([@bib28]), we evaluated PLC phosphorylation following treatment of rMMs with 1 or 50 ng/ml LIF. As shown in [Figure 5](#fig5){ref-type="fig"}B, 1 ng/ml LIF induced a small, brief elevation of PLCγ1 phosphorylation for a 5- to 10-min time period, whereas 50 ng/ml LIF caused a robust increase in phosphorylation for at least 60 min. Simultaneously, pSTAT3 and 5 remained greatly elevated at both LIF concentrations, suggesting that a differential in PLCγ1 phosphorylation may contribute to the concentration-dependent responses and that this balance may help determine when the progenitor commits or self-renews. Conversely, knockdown of PLCγ1 over 72 hr caused an increase in SIX2 levels in immunoblots of FTLY-cultured rMMs ([Figure 5](#fig5){ref-type="fig"}C), suggesting that it may play a regulatory role in lineage commitment.

Y27632 Attenuates JNK Signaling and Activates *Slug* Expression when Combined with LIF {#sec2.7}
--------------------------------------------------------------------------------------

JNK inhibitors block expression of differentiation markers, including *E-cadherin*, in mMMs ([@bib18]). In rMM cells, 1 ng/ml LIF weakly activated the 46-kDa form of pJNK, whereas 50 ng/ml greatly elevated phosphorylation of both the 46- and 55-kDa pJNK isoforms after only 15 min of treatment ([Figure 5](#fig5){ref-type="fig"}D). Moreover, the JNK inhibitor SP600125 abrogated the expression of *Lim1* and *E-cadherin* in rMM cells treated for 6 days ([Figure 5](#fig5){ref-type="fig"}E). The EMT regulatory factor *Slug/Snai2*, which is expressed in MM progenitors ([@bib26]), was also evaluated in response to LIF treatment. LIF (50 ng/ml) inhibited *Slug* expression in rMMs treated for 6 days ([Figures 5](#fig5){ref-type="fig"}F and 5G) unless partnered with a JNK inhibitor with which it stimulated *Slug* levels instead ([Figure 5](#fig5){ref-type="fig"}G). These findings provide strong evidence that LIF plays a dual role in cells. Through STAT signaling, it supports stemness by selecting SIX2+ cells or inducing SIX2 expression while also activating PLC and JNK to facilitate MET.

Rho kinase regulates JNK signaling by activating/phosphorylating JNK itself ([@bib16]). As predicted, Y27632 attenuates JNK phosphorylation of both the 46- and 55-kD isoforms ([Figure 5](#fig5){ref-type="fig"}D). Interestingly, LIF with Y27632 also stimulated *Slug* expression in rMMs treated for 6 days ([Figure 5](#fig5){ref-type="fig"}H), as observed with the JNK inhibitor ([Figure 5](#fig5){ref-type="fig"}G). These findings suggest that Y27632 helps maintain rMMs by inhibiting their differentiation through attenuation of JNK activity.

LIF Induces YAP, which Regulates Several rMM Stemness Markers {#sec2.8}
-------------------------------------------------------------

YAP is involved in the regulation of MM progenitors both in vivo and in short-term primary culture ([@bib8]). In those studies, it was predominantly nuclear localized in cultured cells at low density but lost from nuclei in rMM cells cultured for 72 hr at high density (arrows), as shown in [Figure 6](#fig6){ref-type="fig"}A. In contrast, FTLY-treated rMM progenitors showed nuclear YAP in cells regardless of density, suggesting that FTLY overcomes any density-dependent repression of YAP signaling. To further investigate this phenomenon, rMM progenitors were cultured in FT medium with LIF or Y27632 for 72 hr and evaluated for YAP or TAZ ([Figure 6](#fig6){ref-type="fig"}B). Although cytosolic levels of YAP/TAZ were similar regardless of treatment, 1 ng/ml LIF greatly increased the nuclear levels of both. Interestingly, Y27632 abrogated this response, but the effect could then be rescued with LIF. These studies suggest that LIF may activate YAP signaling in rMM cells and demonstrate that LIF and Y27632 play distinct but complementary roles in maintaining the MM progenitor.

To determine whether YAP also stabilizes stem marker expression in rMM progenitors, FTLY-treated cells were transfected with *Yap* siRNA and cultured for 72 hr. This resulted in a substantial loss of YAP and the downregulation of expression of all stem markers, including SIX2, CITED1, PAX2, and SALL1 ([Figure 6](#fig6){ref-type="fig"}C), suggesting that it plays a major role in the regulation of key stem cell regulatory factors. *Yap* knockdown also caused a concomitant increase in the expression of the differentiation markers *Pax8*, *E-cadherin*, and *Lim1* ([Figure 6](#fig6){ref-type="fig"}D). Conversely, knockdown of PLCγ not only upregulated SIX2 expression, as described earlier, but also upregulated YAP expression ([Figure 5](#fig5){ref-type="fig"}C). This suggests that YAP and calcium signaling function in tandem to balance MM progenitor commitment to nephronic differentiation and that loss of nuclear YAP is sufficient to permit MET.

YAP Functions in MM Progenitors by a TEAD-Dependent Mechanism {#sec2.9}
-------------------------------------------------------------

To directly determine whether the canonical YAP transcriptional partner TEAD mediates YAP activity in rMMs, all four TEAD family members were knocked down collectively in cells, which were then analyzed for the induction of the differentiation markers *E-cadherin* and *Pax8*. Expression levels for each individual TEAD were depressed significantly following knockdown ([Figure S6](#mmc1){ref-type="supplementary-material"}B) and resulted in an upregulation of both *Pax8* and *E-cadherin* ([Figure 6](#fig6){ref-type="fig"}E). Therefore, YAP likely functions through TEAD activation to suppress the differentiation of rMM progenitors.

Discussion {#sec3}
==========

In this study, we define serum-free culture conditions that permit the massive, rapid, and preferential expansion of SIX2+ MM progenitors with the preservation of a stem-like phenotype. Furthermore, the cells derived from these conditions retain their capacity to form nephronic tubules and glomeruli when induced with embryonic spinal cord and remain responsive to inductive signals after multiple passages. This is the first evidence showing that functional nephronic progenitors can be maintained in culture long-term. We also demonstrate the efficacy of genetically manipulating these cells and interrogating specific signaling mechanisms through gene-targeted knockdowns.

Previously we reported the propagation of rMM progenitors with FT medium and short-term retention of functionality ([@bib32]), but, here, we demonstrate that cells lose *Six2* and *Pax2* expression in primary culture and become unresponsive to inductive signals. SIX2+/PAX2− mMMs were passaged successfully as nephrospheres, but the cells failed to epithelialize at any passage ([@bib15]). PAX2 facilitates competency in mMM progenitors, allowing them to undergo MET ([@bib5]), and is likely required for the long-term inducibility of these cells. As shown here, the combination of LIF and Y27632 sustained *Pax2* expression in rMMs and stimulated nuclear levels of pPAX2. Therefore, both SIX2 and PAX2 may be functional determinants for the successful culture of nephronic stem cells.

FTLY preferentially expanded the SIX2+ population in our mixed MM cultures. The exact basis for this is unknown but may be due to the elaboration of the LIF receptor on cap mesenchyme cells ([@bib23]). In embryonic rat kidney, LIFR antibody labeled the membranes of cap cells, whereas membrane staining of the interstitial stroma was not apparent. By whatever mechanism, the selectivity complicates our findings because many of our experiments were performed over a 7- to 10-day period, during which selection had occurred. Regardless, the use of an internal low-affinity binding site as the control should have partially mitigated any selectivity in our ChIP experiments. Moreover, the combination of STAT redundancy, partial retention of SIX2, and 3-day time points should have precluded the selective loss of SIX2+ cells in the *Stat* knockdown studies. Still, further study of the direct role of LIF on *Six2* expression in these cells is clearly warranted.

We demonstrate that LIF affects signaling in MM progenitors in a concentration-dependent manner ([Figure 7](#fig7){ref-type="fig"}; [Figure S7](#mmc1){ref-type="supplementary-material"}). At 1 ng/ml, it induces phosphorylation primarily of STATs 1, 3, and 5 as well as the expression of several progenitor markers, whereas, at 50 ng/ml, it additionally activates both PLCγ and JNK. Because the higher concentration of LIF is associated with the induction of MET and nephronic tubule formation ([@bib2; @bib23]), it is possible that PLCγ and JNK are involved in those morphogenetic processes. The PLCγ metabolite IP3 activates PROTEIN KINASE C, which initiates an intracellular calcium cascade. Because knockdown of PLCγ upregulated the expression of the stem markers SIX2 and YAP, it is likely that LIF-activated PLCγ helps override the stemness program to direct cells to form tubules. This is supported by the fact that *PLC*γ-deficient chimeric mice develop cystic kidneys, a symptom of aberrant tubular proliferation ([@bib27]).

In this study, LIF also induced JNK phosphorylation and upregulated the expression of the differentiation markers *Lim1* and *E-cadherin*. This induction was attenuated by treatment with a JNK inhibitor. Furthermore, both the JNK and ROCK inhibitors facilitated expression of the progenitor marker *Slug* but, interestingly, only in concert with LIF. These findings suggest that the role of Y27632 may be to limit the LIF-induced, JNK-mediated differentiation of rMMs and, instead, help sustain cells in a more primitive state.

Yap plays a major role in maintaining the pluripotency of mouse ESCs (mESCs), and LIF is in part responsible for sustaining YAP expression in those cells ([@bib31]). In turn, YAP stimulates LIF receptor expression, facilitating mESC competency to respond to LIF. Furthermore, YAP complexes with a TEAD family member to activate transcription of LIF-dependent targets in mESCs. We provide the first evidence showing that LIF functions similarly in MMs by increasing nuclear levels of YAP and sustaining the expression of several MM stemness markers. We also found that YAP signals in MMs through a canonical mechanism involving TEAD transcriptional activation, as observed for mESCs. *Tead-2/4* are both expressed in MMs (GUDMAP, Andrew P. McMahon lab) and are therefore the most likely to co-localize with YAP/TAZ ([@bib8]). Moreover, FTLY stimulated proliferation of MM progenitors and permitted nuclear localization of YAP even in areas of high density. This suggests that the combined treatment of LIF and Y27632 on MM cells constitutively activates YAP and may explain not only the dramatic growth observed in treated cultures but also the retention of a stem-like phenotype of the progenitors in long-term cultures.

Although our studies bring new attention to the role of LIF/JAK/STAT signaling in regulating stemness of the MM progenitor, we have yet to address how this may interface with the established role of β-CATENIN in this process. Mouse genetic studies have clearly implicated canonical WNT signaling in the maintenance of the MM progenitor ([@bib12; @bib19]). Because a combination of LIF and a WNT is sufficient to support the expansion of germline-competent mouse ESCs ([@bib33]), it is intriguing that both may also be necessary for the long-term propagation of MM progenitors. As indicated, our current conditions do not preserve the capacity of cells to form tubules over several passages. This is likely due to the depletion of progenitors that commit spontaneously to primitive epithelia. Perhaps a deficiency in canonical WNT signaling is responsible, a possibility currently under investigation.

Experimental Procedures {#sec4}
=======================

Tissues and Primary MM Cell Cultures {#sec4.1}
------------------------------------

Metanephric mesenchymes were enzymatically separated from T-shaped ureteric buds of E13.5 rat or E11.5 mouse embryos as described previously ([@bib20]) and cultured as described by [@bib32]. Cells were dissociated with 0.25% trypsin-EDTA solution (Gibco-Invitrogen) and washed with PBS for passaging.

Cell Proliferation Assay {#sec4.2}
------------------------

Primary cultures of rMM cells were trypsinized, and cells (1--9 × 10^4^ cells/well) were plated in a 96-well plate and treated as indicated for 72 hr. Cell viability and growth were assessed using WST-1 cell proliferation reagent (Roche Applied Science) according to manufacturer's instructions.

Population Analysis {#sec4.3}
-------------------

Cells were seeded in four-chamber fibronectin-coated slides at 50,000 cells/chamber, fixed after 24 hr (unless expanded as primaries for 7 days), and probed for SIX2 (nephronic progenitors) or PBX1 (stroma). Counts of cells with stained nuclei were compiled from an analysis of 500--2,000 cells/slide using a Zeiss LSM710 confocal microscope. All points were generated from three independent cultures.

Colony Assay {#sec4.4}
------------

Colony formation by MM progenitors was performed as described previously ([@bib18]) with minor modifications. A clone of WNT4-expressing NIH 3T3 cells (Andreas Kispert) was selected for high WNT4 expression (Jeffrey Rubin) and used as a feeder layer for these studies. Mitomycin C-treated feeder cells were seeded in 12-well dishes (500,000 cells/well) in DMEM with 10% FBS. The following day, the medium was replaced with colony assay medium, and MM cells (100,000/well) were added. Colony formation was assessed after 7 days.

Animals {#sec4.5}
-------

All animal procedures were performed following guidelines from the National Cancer Institute (NCI)-Frederick Animal Care and Use Committee. NCI-Frederick is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International and follows the Public Health Service Policy for the Care and Use of Laboratory Animals. Animal care was provided in accordance with the procedures outlined in the Guide for Care and Use of Laboratory Animals (National Research Council, 1996, National Academy Press, Washington, D.C.).

Semiquantitative RT-PCR {#sec4.6}
-----------------------

Analyses were performed as described previously ([@bib32]). Primer sequences, annealing temperatures, and cycle parameters are shown in [Table S1](#mmc1){ref-type="supplementary-material"}.

Immunoblotting {#sec4.7}
--------------

Immunoblotting was performed as described previously ([@bib32]).

Cell Fractionation {#sec4.8}
------------------

Nuclear and cytosolic proteins were prepared according to [@bib9]. Briefly, cells were treated for 72 hr, harvested in cold PBS, and pelleted (500 × *g*) for 5 min. Pellets were lysed with buffer A (10 mM HEPES-KOH \[pH 7.9\], 10 mM KCl, 0.1 mM EDTA, 0.5% Nonidet P-40, 1 mM dithiothreitol, and 0.5 mM phenylmethylsulfonyl fluoride \[PMSF\]) on ice for 20 min and centrifuged (14,000 × *g*) for 15 min at 4°C. Supernatants served as cytoplasmic fractions. Nuclear pellets were washed three times with buffer A and resuspended in buffer B (20 mM HEPES, 0.5 M KCl, 1 mM EDTA, 1 mM dithiothreitol, and 1 mM PMSF \[pH 7.9\]) for 30 min at 4°C on a rotating wheel and centrifuged at 14,000 × *g* for 15 min at 4°C. One part of the cytosolic and nuclear fractions was analyzed using anti-LAMIN A/C or anti-GAPDH antibody. Protein concentration was determined using a protein assay kit (Bio-Rad) according to the manufacturer's instructions.

Plasmids and Electroporation {#sec4.9}
----------------------------

Transfections were performed as described previously ([@bib32]), except with 2 μg plasmid and 5 × 10^5^ cells/transfection. After 24 hr, cells were harvested with TRIzol reagent (Invitrogen) for RNA isolation. Transfection efficiencies were greater than 90%.

siRNA Transfection {#sec4.10}
------------------

siRNA reagents were transfected into rat MM cells by Lipofectamine RNAi MAX (Invitrogen) reagent using the manufacturer's protocol. The culture medium was changed 24 hr after transfection, and transfection efficiency was analyzed by qRT-PCR or immunoblotting.

Immunocytochemistry/Immunofluorescence {#sec4.11}
--------------------------------------

Primary MM cells were cultured on four chamber matrix-coated slides. Cells were fixed (4% paraformaldehyde/10 min) and processed according to Abcam's immunocytochemistry protocol (<http://www.abcam.com/index.html?pageconfig=popular_protocols>), blocking with 10% goat serum and mounting in Vectashield (Vector Laboratories). Cells were visualized on an LSM710 confocal microscope (Carl Zeiss) and analyzed by ZEN image software (Zeiss). IF staining for nephron segment-specific markers was performed as described previously ([@bib30]).

Chromatin Immunoprecipitation Assay {#sec4.12}
-----------------------------------

The 5-kb upstream promoter region of mouse *Six2* was interrogated for known transcription factor binding elements using the web-based TFSearch program ([http://diyhpl.us/∼bryan/irc/protocol-online/protocol-cache/TFSEARCH.html](http://diyhpl.us/%7Ebryan/irc/protocol-online/protocol-cache/TFSEARCH.html){#intref0015}). "*Statx*" sites with a score of ≥90 were probed for STAT3 binding by ChIP. Primary mMM cells were cultured as described previously in FT medium with or without LIF (5 ng/ml) for 6--8 days in 60-mm dishes. ChIP was done as described previously ([@bib14]). Briefly, cells were fixed (1% paraformaldehyde/15 min) and sonicated (60 min) on ice using a Bioruptor at low power and a 30-s on/off oscillation program (average fragmentation of 500--1,000 bp). Recruitment of STAT3 to target DNA elements was evaluated by PCR or qPCR following immunoprecipitation of STAT3 (Cell Signaling Technology, antibody 9139S). Primers are shown in [Table S1](#mmc1){ref-type="supplementary-material"}.

Statistical Analysis {#sec4.13}
--------------------

Data were evaluated as described previously using Student's t test ([@bib32]). All experiments were performed independently at least three times. Error bars represent the variation from three or more independent experiments.
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![LIF and Y27632 Support the Retention of Progenitor Marker Expression in Cultured MMs\
(A) Schematic of the MM cell culture method. Isolated rat or mouse MMs were explanted on culture dishes in serum-free medium.\
(B and C) Expression levels of the progenitor markers *Six2* and *Pax2* (B) and the differentiation marker *E-cadherin* (C) in cells grown in control (FT) medium or LIF or Y27632 for 10 days on laminin. Uncultured rMMs at E13.5 were used for comparison.\
(D) RT-PCR expression profiles for cells grown in FT or FTLY medium on fibronectin. Uncultured rMMs served as controls. noRT, no reverse transcriptase control.](gr1){#fig1}

![FTLY Preferentially Expands the SIX2+ MM Progenitor\
(A) FTLY medium preserves nuclear staining for SIX2 and PAX2. Scale bars, 100 μm.\
(B) FTLY medium significantly increases the proportion of SIX2+ progenitors over time/passaging in mixed rMM populations (^∗^p \< 0.05). Error bars show variation from three to four independent cultures.\
(C) FTLY treatment significantly decreases the proportion of PBX1+ stromal cells over time/passaging. (^∗^p \< 0.05). Error bars show variation from three to four independent cultures.\
(D) SIX2 expression levels decline with rMM passaging (P) in four separate cultures (n1--n4). E-CADHERIN is not detected.\
(E) FTLY treatment preserves the expression of progenitor markers despite multiple (five) passages. Uncultured rMMs served as controls.](gr2){#fig2}

![FTLY-Treated rMMs Remain Competent to Respond to Induction and Form Tubules\
(A) WNT4 (100 ng/ml) induces the differentiation markers *Lim1* or *E-cadherin* in FTLY-treated rMMs. Cells were treated for 72 hr and analyzed by qPCR.\
(B) Passaged FTLY-treated rMM cells also respond to inductive cues. Passage 5 cells treated with LIF (50 ng/ml) or CHIR99021 (CHIR, 1μM) for 72 hr upregulate *Lim1* and *E-cadherin*, as shown by RT-PCR.\
(C) Passaged FTLY-treated rMM cells form colonies on NIH 3T3WNT4 feeder cells. Isolated rMM cells served as controls.\
(D) rMM cells propagated in FTLY medium form mature renal tubules and glomerular-like structures. rMM cells cultured and passaged in FT or FTLY medium were H&E-stained or probed for expression of the nephronic markers WT1 (condensed mesenchyme or podocytes), NEPHRIN (podocytes/glomeruli), CADHERIN6 (CDH6, proximal tubules), and E-CADHERIN (ECDH, distal tubules). Scale bars, 50 μm.](gr3){#fig3}

![LIF Activates STATs, which Regulate SIX2 Expression\
(A) LIF induces phosphorylation of multiple STATs in a dose-dependent manner. Passaged rMM cells were treated with LIF for 15 min.\
(B) *Stat* siRNA knockdown inhibits SIX2 expression. rMM cells were analyzed 72 hr after transfection.\
(C) LIF and Y27632 enhance nuclear levels of SIX2 and pPAX2. GAPDH marks the cytosolic fraction and LAMIN A/C the nuclear fraction.\
(D) STAT3 binds to the *Six2* proximal promoter in primary mMM cells. Top: schematic of two putative *Stat* response elements (*StatRE*) within the 5-kb upstream proximal promoter of the mouse *Six2* locus. Center: ChIP-PCR demonstrating that the promoter-established STAT3 target *Socs3* is bound by STAT3 in response to LIF. Bottom: ChIP qPCR analysis revealing binding of STAT3 to the upstream (*StatRE1*) region of *Six2* under LIF-stimulated conditions. mMM cells were treated until confluency with FT or FTL (LIF = 5 ng/ml) prior to fixation. IP, immunoprecipitation.](gr4){#fig4}

![LIF Activates PLCγ and JNK in a Dose-Dependent Manner\
(A) Calcium/NFAT signaling mediates LIF-induced MET. rMMs were treated with LIF (50 ng/ml) in the presence of the calcium/NFAT inhibitor CsA (10 μM) or the β-CATENIN inhibitor CT-HC-1 (10 μM) for 6 days and analyzed for the MET markers *Lim1* and *E-cadherin*.\
(B) LIF differentially activates PLCγ. Passaged rMM cells were treated with 1 or 50 ng/ml LIF.\
(C) PLCγ negatively regulates SIX2 and YAP expression. rMM cells transfected with *Plc*γ siRNA were harvested after 72 hr.\
(D) Y27632 attenuates LIF-induced JNK phosphorylation. Cells were pretreated with Y27632 (10 μM) for 30 min and then with LIF for 15 min.\
(E) JNK facilitates LIF-induced MET in rMMs. rMMs were treated with LIF (50 ng/ml) or the JNK inhibitor SP600125 (10μM) for 6 days.\
(F) LIF suppressed *Slug/Snai2* expression during MET. rMMs were treated with LIF (50 ng/ml) for 6 days.\
(G) SP600125 reverses the LIF-induced suppression of *Slug* in rMM cells. rMMs were treated with LIF (50 ng/ml) or SP600125 (10μM) for 6 days.\
(H) LIF (1 ng/ml) plus Y27632 stimulates *Slug* expression in cultured rMM cells.](gr5){#fig5}

![YAP Regulates Progenitor Markers\
(A) LIF and Y27632 override density-dependent signals for nuclear localization of YAP. White arrows indicate dense areas lacking Yap nuclear localization. Scale bars, 100 μm.\
(B) LIF increases nuclear levels of YAP/TAZ. Cells were cultured for 72 hr (LIF, 1 ng/ml). GAPDH and LAMIN A/C distinguished fractions.\
(C) *Yap* knockdown decreased progenitor marker expression in rMM cells.\
(D) Silencing *Yap* increased the expression of differentiation markers in rMM cells.\
(E) *Tead* knockdown upregulated differentiation markers in rMM cells.](gr6){#fig6}

![Model of MM Induction (A) or Stem Cell Stabilization (B) Based on Our Findings with LIF and Y27632.](gr7){#fig7}
